Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2026	Jan. 31, 2025	Jan. 31, 2024
Cash flows from operating activities
Net loss	$ (59,342)	$ (81,935)	$ (75,569)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	9,835	9,236	6,622
Non-cash lease expense	5,582	4,399	4,318
Amortization of contract acquisition costs	18,910	17,524	17,770
Stock-based compensation expense	56,055	59,366	64,348
Loss on extinguishment of debt	0	1,850	0
Remeasurement of warrant liability	(1,959)	150	0
Other, net	9,033	6,209	4,735
Change in operating assets and liabilities:
Accounts receivable, net	(13,912)	(4,347)	11,761
Contract acquisition costs	(29,625)	(17,492)	(15,324)
Prepaid expenses and other assets	2,411	123	(1,593)
Accounts payable	8,882	1,829	(6,974)
Operating lease liabilities	(6,665)	(5,334)	(5,177)
Accrued expenses and other liabilities	8,924	6,252	(4,438)
Deferred revenue	(195)	(6,882)	2,104
Net cash provided by (used in) operating activities	7,934	(9,052)	2,583
Cash flows from investing activities
Purchases of property and equipment	(9,954)	(9,445)	(11,734)
Purchases of intangible assets	0	0	(26)
Net cash used in investing activities	(9,954)	(9,445)	(11,760)
Cash flows from financing activities
Payments of deferred offering costs for registration statement	(164)	(1,003)	0
Proceeds from shares issued in connection with employee stock purchase plan	1,333	1,910	3,406
Shares repurchased for tax withholdings on vesting of restricted stock	(3,245)	(820)	0
Debt issuance proceeds (costs), net		52,758	0
Debt issuance proceeds (costs), net	(206)
Repayment of debt and related fees	0	(53,177)	0
Proceeds from short-term payable financing	14,764	12,694	0
Payments on short-term payable financing	(14,682)	(8,971)	0
Proceeds from exercise of stock options	0	0	65
Net cash provided by (used in) financing activities	(2,200)	3,391	3,471
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	1,907	(569)	145
Net decrease in cash, cash equivalents, and restricted cash	(2,313)	(15,675)	(5,561)
Cash, cash equivalents, and restricted cash at beginning of period	45,264	60,939	66,500
Cash, cash equivalents, and restricted cash at end of period	42,951	45,264	60,939
Supplemental disclosures of cash flow information
Cash paid (received) for income taxes, net	(32)	1,166	577
Cash paid for interest	9,971	12,117	12,593
Non-cash investing and financing activities
Operating lease right-of-use assets obtained for lease liabilities	7,159	2,863	806
Purchases of property and equipment included in accounts payable and lease liabilities	166	416	329
Stock-based compensation capitalized as internal-use software	2,203	2,406	2,509
Debt issuance costs in accounts payable and accrued liabilities	0	206	0
Deferred offering costs for registration statement in accounts payable and accrued liabilities	0	164	0
Issuance of warrants in connection with credit facility	$ 0	$ 11,058	$ 0